 |
인쇄하기
취소
|
Samjin new anti-AIDS compound attracting academic interests.
Samjin Pharm. announced on May 15 that the company made a technical licensing out agreement for a new drug of AIDS therapy with ImQuest, an American new drug R&D company.
ImQuest delivered a presentation on the subject of Samjin's new AIDS drug during the 19th ICAR conference at Puerto Rico from May 7 to 11, covering that the new anti-HIV compound developed by Samjin showed a complete eradi...
ImQuest delivered a presentation on the subject of Samjin's new AIDS drug during the 19th ICAR conference at Puerto Rico from May 7 to 11, covering that the new anti-HIV compound developed by Samjin showed a complete eradi...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.